Manufacturing and Production

Showing 15 posts of 5860 posts found.

Brennan bows to pressure and quits AstraZeneca

April 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

Merck KGaA swings axe over Serono operations

April 25, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …
Novartis image

Novartis to invest $550m in new Swiss plant

April 24, 2012 Manufacturing and Production GSK, Novartis, manufacturing and production

Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …

7 steps to better talent acquisition

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives

When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …
tom_pike_500_pixels_wide_-_quintiles

Quintiles appoints Tom Pike as new chief executive

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical

Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …

GSK to bring pharma plant in Sri Lanka online

April 24, 2012 Manufacturing and Production BMS, GSK. Sri-Lanka, manufacturing and production

GlaxoSmithKline is due to open a newly-built manufacturing facility in Sri Lanka this week that is said to be the …

Mylan earmarks €380m for Irish expansion

April 24, 2012 Manufacturing and Production Galway, Ireland, Mylan, manufacturing and production

Generic drugmaker Mylan has announced a plan to invest €380 million in its operations in the Republic of Ireland, including …

Baxter planning $1 billion plasma facility for Atlanta

April 24, 2012 Manufacturing and Production Atlanta, baxter, manufacturing, production

Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …

Falsified Medicines Directive in the EU

April 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dated 16 April 2012, the European Commission has issued the Draft Template for the Written Confirmation for Active Substances Imported …

EMA request feedback on the draft EU reference dates

April 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide comments on the draft list …
cloud computing image

Pharmaceutical marketers – put your head in the clouds

April 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Blyth, Cloud Computing, MSI, digital, iPod, ipad

The moment has arrived for the pharma industry to embrace online planning tools.The convergence of reliable and secure cloud-based computing, …

China bans medicines formulated in toxic capsules

April 17, 2012 Manufacturing and Production China, SFDA, impurities, manufacturing

China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …

Pharma manufacturing news in brief

April 17, 2012 Manufacturing and Production Intertek and Pharmatek Labs, Jubilant, Penn Pharma

Raw material issues disrupting pharma production in Pakistan, Jubilant opens a new plant in Gujarat, plus updates from Penn Pharma, …
lechleiter_john_300dpi

Lilly’s John Lechleiter elected as PhRMA Board chairman

April 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …

Lonza lined up as backup manufacturer for Agennix’s talactoferrin

April 16, 2012 Manufacturing and Production Agennix, DSM Pharmaceutical, Lona

Agennix has taken a ‘belt-and-braces’ approach to manufacturing its lead pipeline product, signing a new deal with Lonza a month …
The Gateway to Local Adoption Series

Latest content